The Bacterial Renaissance: How Synthetic Biology is Engineering a New Frontier in Cancer Therapy

Synthetic biology is transforming bacteria into living cancer therapies—capable of infiltrating tumors, activating immune responses, and reshaping the future of precision oncology. For decades, cancer treatment has relied on the familiar triad of surgery, chemotherapy, and radiation. More recently, immunotherapy has offered new hope, especially with checkpoint inhibitors and CAR-T cells reshaping treatment landscapes. Immunotherapy…

IDST Monthly Access Membership Required

You must be a IDST Monthly Access member to access this content.

IDST Pro Access Required

This analysis is part of IDST premium intelligence.

Subscribe to Continue Reading